NCT03147937

Brief Summary

Patients assume that cognitive performance rapidly returns to baseline after anesthesia and surgery. Several studies have shown that one week after major non-cardiac surgery about 27% of patients have postoperative cognitive dysfunction (POCD) and 10% of patients at 3 months. Very few studies have assessed the incidence of POCD beyond 3 months. POCD significantly reduces quality of life. Identifying risk factors for POCD is important because it is associated with prolonged hospital stay, loss of independence, and premature retirement. There is an urgent need to measure and document the level of cognitive change associated with surgery with an easy to use tool, both prior to admission and after discharge. This information can be used to plan appropriate care paths and to identify or test the efficacy of potential new treatments to alter the negative trajectory.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
505

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2017

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

May 8, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 10, 2017

Completed
8.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

September 5, 2025

Status Verified

September 1, 2025

Enrollment Period

8.6 years

First QC Date

May 8, 2017

Last Update Submit

September 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients with Cognigram score decreasing by > 2 SDs from baseline at 4.5

    Proportion of patients with Cognigram score decreasing by \> 2 SDs from baseline at 4.5

    4.5 months from baseline

Secondary Outcomes (5)

  • Proportion of patients with Cognigram score decreasing between 1 and 2 standard deviations from baseline at 4.5 months

    4.5 months from baseline

  • Effect of pre-operative MCI on postoperative cognitive changes at 4.5 months

    4.5 months from baseline

  • Effect of pre-operative chronic inflammatory states on postoperative cognitive changes at 4.5 months

    4.5 months from baseline

  • Effect of postoperative delirium on postoperative cognitive changes at 4.5 months

    4.5 months from baseline

  • Effect of postoperative complications on postoperative cognitive changes at 4.5 months

    4.5 months from baseline

Interventions

Computerized CogState Brief Battery (CBB), Cognigram, assesses changes in four cognitive domains including psychomotor function, attention, learning and memory, and working memory. The CBB is a computerized test based on card games that can be administered online

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing total hip arthroplasty (THA) or total knee arthroplasty (TKA) at the Holland Orthopedic and Arthritic Centre (HOAC) at Sunnybrook Health Sciences Centre (SHSC).

You may qualify if:

  • All patients ≥ 50 years of age undergoing elective total hip or knee arthroplasty at Sunnybrook Health Sciences Centre

You may not qualify if:

  • Lack of informed consent
  • Inability to comply with study procedures or follow-up visits
  • Patients with diagnosed dementia or those being treated with donepezil (Aricept®)
  • Patients with severe cognitive impairment defined as baseline with a CBB score of equal to or less than 80 in at least one of the 4 CBB domains
  • Patients with uncontrolled psychiatric diagnoses including schizophrenia, bipolar disorder, major depressive mood disorder
  • Patients undergoing a second joint replacement \& previously enrolled in this study within the past 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sunnybrook Health Sciences Centre

Toronto, Ontario, M4N 3M5, Canada

Location

Related Publications (1)

  • Choi S, Avramescu S, Orser BA, Au S. Protocol for a prospective cohort study of assessing postoperative cognitive changes after total hip and knee arthroplasty in the Greater Toronto area. BMJ Open. 2019 Feb 24;9(2):e024259. doi: 10.1136/bmjopen-2018-024259.

MeSH Terms

Conditions

Postoperative Cognitive ComplicationsCognitive DysfunctionDeliriumAutoimmune DiseasesInflammation

Interventions

Neuropsychological Tests

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental DisordersConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsImmune System Diseases

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Officials

  • Stephen Choi, MD,FRCPC,MSc

    Sunnybrook Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, FRCPC, MSc

Study Record Dates

First Submitted

May 8, 2017

First Posted

May 10, 2017

Study Start

May 1, 2017

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

September 5, 2025

Record last verified: 2025-09

Locations